Drugmakers Boost Prices Despite Political Risks
One thing big drug companies generally aren't keen on is being the focus of a hot political debate. In the past, the quickest way to become Exhibit...
One thing big drug companies generally aren't keen on is being the focus of a hot political debate. In the past, the quickest way to become Exhibit...
New York Times | GARDINER HARRIS and NATASHA SINGER | Posted 05.25.2011
At least a dozen major drug and device makers are under investigation by federal prosecutors and securities regulators in a broadening bribery inquiry...
AP | MATTHEW PERRONE | Posted 11.17.2011
WASHINGTON — The Food and Drug Administration said Tuesday it will begin asking doctors to keep an eye out for misleading drug advertisements as...
AP | ERICA WERNER | Posted 05.25.2011
WASHINGTON — The head of the influential trade association for drug manufacturers announced Thursday night that he is leaving his job. The deve...
New York Times | DUFF WILSON | Posted 05.25.2011
Even as drug makers promise to support Washington's health care overhaul by shaving $8 billion a year off the nation's drug costs after the legislatio...
Wall Street Journal | ALICIA MUNDY and LAURA MECKLER | Posted 05.25.2011
WASHINGTON -- The pharmaceuticals industry, which President Barack Obama promised to "take on" during his campaign, is winning most of what it wants i...
Maggie Mahar | Posted 05.25.2011
Forces calling for health care reform are gaining momentum. But if by "reform," they simply mean "universal coverage," I have to disagree.
www.npr.org | Posted 01.14.2012